Maxis AI is pioneering the future of clinical development with its Agentic AI platform, creating a hybrid, human-AI workforce, where intelligent AI agents and augmented human experts collaborate to conquer complexity. We empower life sciences organizations to move beyond the linear model of rising costs and timelines, enabling them to orchestrate trials with unprecedented speed, precision, and trust. Built upon the foundation of 3300 plus clinical trials’ execution experience and domain context, our enterprise-ready Agentic AI platform is "Designed to Think. Built to Act".
It automates and optimizes end-to-end workflows, from study start up to regulatory submissions. We provide a fully governed, compliant, and integrated ecosystem that transforms human intent into intelligent action, delivering measurable results and accelerating the entire drug development lifecycle.
Our mission is to transform the operating model of clinical research, ensuring that the most innovative therapies reach patients faster. Maxis AI serves pharma, biotech, medical devices, and CROs of all sizes, with partnerships including academic medical centers and site networks.
Discover more at www.maxisai.com
